Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for TMJ Dysfunction
NCT03675659Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Sep 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of magnesium sulfate in temporomandibular joint disorders (TMD) (2 arms), sponsored by Cairo University. Primary endpoint: Visual Analog Scale at 1 year. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT03675659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03675659.